期刊的影响因子--文章列表

期刊文章列表
Dongrong Yi，Quanjie Li，Han Wang，Kai Lv，Ling Ma，Yujia Wang，Jing Wang，Yongxin Zhang，Mingliang Liu，Xiaoyu Li，Jianxun Qi，Yi Shi，George F.Gao，Shan Cen（Institute of Medicinal Biotechnology；CAS Key Laboratory of Pathogenic Microbiology and Immunology；University of Chinese Academy of Sciences；CAMS Key Laboratory of Antiviral Drug Research）.Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein[J].药学学报(英文版),2022,第12期 Xiwei Ji，Xiangrui Meng，Xiao Zhu，Qingfeng He，Yimin Cui（Institute of Clinical Pharmacology；Xiyuan Hospital；Department of Clinical Pharmacy and Pharmacy Administration）.Research and development of Chinese anti-COVID-19 drugs[J].药学学报(英文版),2022,第12期 Wan Li，Hongqing Cai，Liwen Ren，Yihui Yang，Hong Yang，Jinyi Liu，Sha Li，Yizhi Zhang，Xiangjin Zheng，Wei Tan，Guanhua Du，Jinhua Wang（The State Key Laboratory of Bioactive Substance and Function of Natural Medicines；Key Laboratory of Drug Target Research and Drug Screen；Department of Neurosurgery；State Key Laboratory of Molecular Oncology；School of Pharmacy；Xinjiang Institute of Materia Medica）.Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways[J].药学学报(英文版),2022,第12期 Deying Yang，Xiang Luo，Qinghai Lian，Lingqiang Gao，Chengxin Wang，Xiaoxiao Qi，Rong Zhang，Zhongqiu Liu，Guochao Liao（Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China；Guangdong-Hong Kong-Macao Joint Lab on Chinese Medicine and Immune Disease Research）.Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development[J].药学学报(英文版),2022,第12期 Chengliang Sun，Yao Cheng，Xiaojia Liu，Gefei Wang，Wenjian Min，Xiao Wang，Kai Yuan，Yi Hou，Jiaxing Li，Haolin Zhang，Haojie Dong，Liping Wang，Chenguang Lou，Yanze Sun，Xinmiao Yu，Hongbin Deng，Yibei Xiao，Peng Yang（State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization；Department of Medicinal Chemistry；Department of Pharmacology；Beijing Institute of Clinical Pharmacy；Department of Physics；Institute of Medicinal Biotechnology）.Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents[J].药学学报(英文版),2022,第12期 Qiang Niu，Yu Liu，Yujing Zheng，Ziwei Tang，Yuna Qian，Ruogu Qi，Jianliang Shen，Ping Zhao（School of Chemistry and Chemical Engineering；State Key Laboratory of Ophthalmology；Wenzhou Institute；School of Medicine&Holistic Integrative Medicine）.Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics[J].药学学报(英文版),2022,第12期 Chuchu Lin，Chenyi Huang，Zhaoqing Shi，Meitong Ou，Shengjie Sun，Mian Yu，Ting Chen，Yunfei Yi，Xiaoyuan Ji，Feng Lv，Meiying Wu，Lin Mei（School of Pharmaceutical Sciences（Shenzhen）；Tianjin Key Laboratory of Biomedical Materials；Academy of Medical Engineering and Translational Medicine）.Biodegradable calcium sulfide-based nanomodulators for H₂S-boosted Ca²⁺-involved synergistic cascade cancer therapy[J].药学学报(英文版),2022,第12期 Kai Tang，Shu Wang，Wenshuo Gao，Yihui Song，Bin Yu（School of Pharmaceutical Sciences）.Harnessing the cyclization strategy for new drug discovery[J].药学学报(英文版),2022,第12期 Minyang Fu，Dandan Peng，Tianxia Lan，Yuquan Wei，Xiawei Wei（Laboratory of Aging Research and Cancer Drug Target）.Author correction to‘Multifunctional regulatory protein connective tissue growth factor(CTGF)：A potential therapeutic target for diverse diseases’[Acta pharmaceutica sinica B 12(2022)1740-1760][J].药学学报(英文版),2022,第12期 Shujing Xu，Xinyong Liu，Peng Zhan（Department of Medicinal Chemistry）.SMIP-30,a potent and selective PPM1A inhibitor with potential to treat tuberculosis[J].药学学报(英文版),2022,第12期 Beifen Zhong，Jun Wan，Changhui Shang，Jiajia Wen，Yujia Wang，Jian Bai，Shan Cen，Youcai Hu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines；Institute of Medicinal Biotechnology）.Biosynthesis of rumbrins and inspiration for discovery of HIV inhibitors[J].药学学报（英文版),2022,第11期 Yuyu Zhu，Zijun Ouyang，Haojie Du，Meijing Wang，Jiaojiao Wang，Haiyan Sun，Lingdong Kong，Qiang Xu，Hongyue Ma，Yang Sun（College of Pharmacy；Instiute of Marine Biomedicine；State Key Laboralony of Pharmaceutical Biotechnology；Jiangsu Key Laborutory of New Drug Research and Clinical Pharmnacy Xuzhou Medical University）.New opportunities and challenges of natural products research：When target identification meets single-cell multiomics[J].药学学报（英文版),2022,第11期 Shilin Chen，Zheng Li，Sanyin Zhang，Yuxin Zhou，Xiaohe Xiao，Pengdi Cui，Binjie Xu，Qinghe Zhao，Shasha Kong，Yuntao Dai（Institute of Herbgenomics；Institute of Chinese Materia Medica；State Key Laboratory of Component Trodional Chinese Medicine；Innovative Instiute of Chinese Medicine and Pharmacy；China Military Instiute of Chinese Medicine）.Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses[J].药学学报（英文版),2022,第11期 Xiaoyou Wang，Chong Li，Yiguang Wang，Huabing Chen，Xinxin Zhang，Cong Luo，Wenhu Zhou，Lili Li，Lesheng Tengh，Haijun Yu，Jiancheng Wang（College of Pharmaceutical Sciences；Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems；School of Radiation Medicine and Protection；Shanghai Institute of Materia Medica；Department of Pharmaceuics；Xiangya School of Pharnaceutical Sciences；CAS Center for Excellence in Nanoscience；School of Life Sciences）.Smart drug delivery systems for precise cancer therapy[J].药学学报（英文版),2022,第11期 Saiyang Xie，Yun Xing，Wenke Shi，Min Zhang，Mengya Chen，Wenxi Fang，Shiqiang Liu，Tong Zhang，Xiaofeng Zeng，Si Chen，Shasha Wang，Wei Deng，Qizhu Tang（Deparment of Cardiology；Hubei Key Laboratory of Metabolie and Chronic Diseases；Cardiovascular Research Instirute of Wuhan Universit）.Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination[J].药学学报（英文版),2022,第11期 Liping Liao，Wenzhen Dang，Tingting Lin，Jinghua Yu，Tonghai Liu，Wen Li，Senhao Xiao，Lei Feng，Jing Huang，Rong Fu，Jiacheng Li，Liping Liu，Mingchen Wang，Hongru Tao，Hualiang Jiang，Kaixian Chen，Xingxing Diao，Bing Zhou，Xiaoyan Shen，Cheng Luo（Deparment of Pharmacology&the Key Laboratory of Smart Drug Delivery；State Key Laboratory of Drug Research；University of Chinese Acadery of Sciences；School of Pharmnaceutical Science and Technologs；School of Pharmaceutical Sciences）.A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1βand IL-6[J].药学学报（英文版),2022,第11期 Zaigang Zhou，Jiashe Chen，Yu Liu，Chunjuan Zheng，Wenjuan Luo，Lele Chen，Shen Zhou，Zhiming Li，Jianliang Shen（State Key Laboratory of Ophalmology；Department of the First Affiliated Hospital of Wenzhou Medical Unaiversity；School&Hospital of Stomatology；Wenzhou Institute；Oujiang Laboratory（Zhejiang Lalb for Regenerative Medicine）.Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy[J].药学学报（英文版),2022,第11期 Zekun Li，Yongchun Pan，Shiyu Du，Yayao Li，Chao Chen，Hongxiu Song，Yueyao Wu，Xiaowei Luan，Qin Xu，Xiaoxiang Guan，Yujun Song，Xin Han（Jiangsu Key Laboratory for Pharmacology and Safery Evaluation of Chinese Materia Medica；College of Engineering and Applied Sciences；Deparment of Oncologs）.Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy[J].药学学报（英文版),2022,第11期 Jie Tu，Na Liu，Yahui Huang，Wanzhen Yang，Chunquan Sheng（School of Pharmac）.Small molecules for combating multidrug-resistant superbug Candida auris infections[J].药学学报（英文版),2022,第11期 Fanxiang Yin，Ran Zhao，Dhilli Rao Gorja，Xiaorong Fu，Ning Lu，Hai Huang，Beibei Xu，Hanyong Chen，Jung-Hyun Shim，Kangdong Liu，Zhi Li，Kyle Vaughn Laster，Zigang Dong，Mee-Hyun Lee（Deparment of Pathophysiology；China-US（Henan）Hormel Cancer Institute；Translational Medical Center；The Hornel Instiute；Depurment of Biomedicine；The Collaborulive Innovalion Center of Henan Province for Cancer Chemoprevention；Department of General Surgery；College of Korean Medicine）.Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo[J].药学学报（英文版),2022,第11期 Yan Li，Ya Chu，Guangjiang Shi，Xiaobin Wang，Wanli Ye，Chun Shan，Dajia Wang，Di Zhang，Wei He，Jingwei Jiang，Shuqian Man，Yuhong Han，Zhili Zhao，Shijia Du，Zhen Chen，Zhiyu Li，Yong Yang，Chen Wang，Xi Xu，Hongxi Wu（Center for New Drug Safety Evaluation and Research；School of Life Science and Technology；School of Pharmacy；Jiangsu Key Lab of Drug Screening）.A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer[J].药学学报（英文版),2022,第11期 Chunying Liu，Shuangrong Ruan，Ying He，Xuejing Li，Yuefei Zhu，Honglan Wang，Hanwei Huang，Zhiqing Pang（Schoo of Pharmacy；The Instiute for Biomedical Engineering&Nano Science；Department of Biomedical Engineering；Institute of Hematology）.Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation[J].药学学报（英文版),2022,第11期 Sang Hoon Lee，Jae Geun Song，Hyo-Kyung Han（College of Pharmacy）.Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hy brid nanocomposite system[J].药学学报（英文版),2022,第11期 Yanli Wu，Yueying Yang，Wang Wang，Dejuan Sun，Jing Liang，Man Zhu，Hua Li，Lixia Chen（Wuya College of Innovation；College of Pharmacy；School of Pharmacy）.PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids[J].药学学报（英文版),2022,第11期 Juan Pang，Jia Nuo Feng，Wenhua Ling，Tianru Jin（Department of Nutrition；Division of Advanced Diagnostics；Department of Physiology；Banting and Best Diabetes Centre）.The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury[J].药学学报（英文版),2022,第11期首页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表